A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin

Research output: Contribution to journalArticlepeer-review

Abstract

Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.

Original languageEnglish
Pages (from-to)978-982
Number of pages5
JournalClinical Case Reports
Volume9
Issue number2
DOIs
Publication statusPublished - Feb 2021

Keywords

  • bulky lymphadenopathy
  • midostaurin
  • purine analogue
  • systemic mastocytosis

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin'. Together they form a unique fingerprint.

Cite this